Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Bayer Pharma Aktiengesellschaft
Bayer Pharma Aktiengesellschaft xfc xdf
  

Bayer Pharma Aktiengesellschaft patents (2016 archive)

Recent patent applications related to Bayer Pharma Aktiengesellschaft. Bayer Pharma Aktiengesellschaft is listed as an Agent/Assignee. Note: Bayer Pharma Aktiengesellschaft may have other listings under different names/spellings. We're not affiliated with Bayer Pharma Aktiengesellschaft, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Bayer Pharma Aktiengesellschaft-related inventors




Date Bayer Pharma Aktiengesellschaft patents (2016 archive) (updated weekly) - BOOKMARK this page
12/22/16Polyethylene glycol based prodrug of adrenomedullin and use thereof
12/22/16Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
12/15/16Aryl- and hetaryl-substituted imidazo[1,2-a]pyridine-3-carboxamides and use thereof
12/01/16Antibody drug conjugates (adcs) with kinesin spindel protein (ksp)
12/01/163-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
11/10/16Determination of a time-dependent contrast agent injection curve as a function of ct scan parameters
11/10/16Heteroaryl substituted pyrazoles
11/03/16Determining the velocity of a fluid using an imaging method
11/03/16Substituted bipiperidinyl derivatives
11/03/16Substituted piperidinyl-tetrahydroquinolines
11/03/16Novel benzimidazole derivatives as ep4 ligands
10/27/16Adenosine a1 agonists as medicaments for kidney disorders
10/27/16Novel indazolecarboxamides, processes for their preparation, pharmaceutical preparations comprising them and their use for producing medicaments
10/20/16Combination of pi3k-inhibitors
10/20/16Combination of pi3k-inhibitors
10/20/16Substituted piperidinyltetrahydroquinolines
10/20/16Substituted bipiperidinyl derivatives
10/13/16Progesterone receptor antagonist dosage form
10/13/16Substituted uracils and use thereof
10/13/16Substituted triazolopyridines
10/13/16Thienopyrimidines as mknk1 and mknk2 inhibitors
10/06/16Substituted-imidazopyridazines
10/06/16Substituted 1,2,4-triazine-3,5-diones and the use thereof as chymase inhibitors
10/06/162-(morpholin-4-yl)-1,7-naphthyridines
10/06/16Novel salts
09/29/16Substituted phenylalanine derivatives
09/29/16Substituted phenylalanine derivatives
09/22/16Substituted phenylalanine derivatives
09/22/16Substituted phenylalanine derivatives
09/22/16Substituted dihydropyrido[3,4-b]pyrazinones as dual inhibitors of bet proteins and polo-like kinases
09/22/16Substituted oxopyridine derivatives
09/15/16Novel compounds
09/15/16Substituted triazolopyridines having activity as mps-1 inhibitors
09/08/16Pharmaceutical dosage forms comprising sodium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1h-1,2,3-triazol-1-yl)-1h-pyrazol-5-olate
09/01/16A novel stable formulation
08/25/16Substituted phenylalanine derivatives
08/25/16Substituted uracils as chymase inhibitors
08/25/16Substituted phenylalanine derivatives
08/25/16Cyclic thienouracil-carboxamides and use thereof
08/18/16Substituted phenylalanine derivatives
08/18/16Substituted phenylalanine derivatives
08/18/16Substituted phenylalanine derivatives
08/18/16Heterocyclic substituted trifluoromethyl pyrimidinones and their use
08/18/16Substituted phenylalanine derivatives
08/18/16Anti-tweakr antibodies and uses thereof
08/04/16Pharmaceutical compositions containing refametinib
08/04/16Disubstituted trifluoromethyl pyrimidinones and their use
08/04/16Substituted phenylalanine derivatives
07/28/16Novel benzimidazole derivatives as ep4 antagonists
07/21/16Prodrug derivatives of substituted triazolopyridines
07/21/16Novel compounds for the treatment of cancer
07/07/16Bet-protein-inhibiting dihydropyridopyrazinones
07/07/16Bet-protein-inhibiting dihydropyridopyrazinones
06/30/16Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof
06/23/16Combination of a imidazopyridazine derivative and a mitotic agent for the treatment of cancer
06/23/16Modified bet-protein-inhibiting dihydroquinoxalinones and dihydropyridopyrazinones
06/23/16Substituted imidazo[1,2-a]pyrazinecarboxamides and use thereof
06/16/16Heteroaryl substituted pyrazoles
06/09/16Substituted pyrazolopyridines
06/09/16Substituted thienopyrimidines and pharmaceutical use thereof
06/02/16Substituted benzylpyrazoles
06/02/16Substituted oxopyridine derivatives and use thereof as factor xia/plasma
05/26/16Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof
05/26/16Heteroaryl substituted pyrazoles
05/26/16Diaminoheteroaryl substituted pyrazoles
05/26/16Heteroaryl substituted pyrazoles
05/19/16Substituted benzoxazoles
05/12/16Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
05/12/16Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines
05/05/163-aryl-substituted imidazo[1,2-a]pyridines and their use
05/05/16Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
05/05/163-aryl-substituted imidazo[1,2-a]pyridines and their use
04/21/16Substituted benzoxazoles
04/21/16Triazolopyridines as thrombin inhibitors for the treatment of thromboembolic diseases
04/07/16Mrg receptor modulators
03/31/16Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
03/31/16Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
03/03/16Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for treating lymphomas
02/25/16Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders
02/25/16Novel compounds
02/25/16Spiroindoline derivatives for use as gonadotropin-releasing hormone receptor antagonists
02/18/16Use of (rs)-s-cyclopropyl-s-(4--5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide for treatment of specific tumours
02/18/16Heteroaryl substituted indazoles
02/18/163-heteroaryl substituted indazoles
01/28/16Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (akr1 c3)
01/21/16Substituted imidazopyridazines
01/14/16Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
01/14/16Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases
01/14/16Substituted thiazolopyrimidines
01/14/16Pdgfrbeta-fc fusion proteins and uses thereof
01/07/16Use and application regimen of a pharmaceutical composition containing levonorgestrel and a cox inhibitor for on-demand contraception
01/07/16Substituted pyrazolopyrimidinylamino-indazoles
01/07/16Benzyl-substituted pyrazolopyridines and use thereof
03/03/16Bis azainositol hafnium complexes for x-ray imaging







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Bayer Pharma Aktiengesellschaft in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bayer Pharma Aktiengesellschaft with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';